Skip to content

Acupoint application of traditional Chinese medicine in the treatment of overactive bladder with urinary incontinence : a double-blind multi-center randomized placebo-controlled clinical study

Acupoint application of traditional Chinese medicine in the treatment of overactive bladder with urinary incontinence : a double-blind multi-center randomized placebo-controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000715
Enrollment
Unknown
Registered
2024-11-19
Start date
2024-12-20
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

Chinese medicine acupoint application group:Apply traditional Chinese medicine herbal poultices at the Shenque, Guanyuan, and Shenshu acupoints. Each treatment session lasts for 16 hours, starting dai
Placebo Group:Prepare a placebo using starch combined with coloring agents and fragrances. Apply the placebo at the Shenque, Guanyuan, and Shenyushu points. The duration of a single treatment is 16 h

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1 age = 18 years old ; 2 the use of drugs in the treatment of urinary incontinence symptoms ineffective ; 3 Subjects with the following conditions in the bladder diary of the 3-day subjects completed in the screening stage : = 3 episodes of urinary incontinence no more than 1 day of urinary incontinence. Frequency of urination ( defined as an average of = 8 urination per day that is a total of = 24 urination ) ;

Exclusion criteria

Exclusion criteria: 1.Serious condition unstable vital signs ; 2.Urinary tract infection urinary calculi interstitial cystitis or recurrent urinary tract infection history ; 3.Obvious bladder outlet obstruction ; 4.Frequent toilets due to severe insomnia ; 5.Patients with severe heart disease ; 6.Patients are currently taking drugs that may affect lower urinary tract function such as a1-adrenergic receptor antagonists diabetes insipidus drugs antidepressants 5areductase inhibitors capsaicin resin toxins or botulinum toxin treatment.

Design outcomes

Primary

MeasureTime frame
Changes in the average daily number of urinary incontinence episodes relative to baseline;

Secondary

MeasureTime frame
Changes in the average daily number of nocturia episodes relative to baseline;Changes in the average daily number of urinary incontinence episodes relative to baseline;Changes in the score of autonomic dysfunction relative to baseline;Changes of urinary flow rate and residual urine volume relative to baseline;

Countries

China

Contacts

Public ContactChang Hong

Xuanwu Hospital Capital Medical University

changhong19791111@163.com13701034090

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026